Neal C. Bradsher, the manager of Broadwood Capital, is still bullish on BioTime, Inc. (NYSEMKT:BTX) and has further increased his fund’s stake in the company. According to a recent Form 4 filing with the Securities and Exchange Commission, Broadwood Capital has added 370,000 shares to its previous position in two transactions, at a price of $2.65 apiece. As a result, Broadwood’s stake surged to approximately 13.8 million BioTime, Inc. (NYSEMKT:BTX) shares, while Bradsher holds an additional 63,000 shares.
Jim Simons has also become a fan of BioTime, Inc. (NYSEMKT:BTX) and has initiated a position for his fund during the first quarter of 2014. In its latest 13F filing, Renaissance Technologies has reported ownership of 51,700 shares. Ken Griffin also sees great potential in this company and has increased his fund’s investment by 9% during the same period. Citadel Investment Group holds approximately 13,800 shares as of March 31, 2014. David E Shaw, on the other hand, has chosen to limit his fund’s exposure to BioTime, Inc. (NYSEMKT:BTX) and has cut its stake by 37% to about 49,300 shares.